Company intelligence / Profile preview

OSO BioPharmaceuticals Manufacturing

Albuquerque, New Mexico, United Statesprnewswire.com ↗

Ownership: Private
Employees: ~138
Development stage: Commercial

Overview

OSO BioPharmaceuticals specialized in the contract manufacturing of complex injectable drugs—including sterile liquids, suspensions, lyophilized formulations—and supported more than 250 commercial products. The company was recognized for its expertise with potent compounds and biologics. It was acquired by Albany Molecular Research Inc. (AMRI) in mid–2014 for $110 million and now operates as part of AMRI’s Drug Product business unit[6][8].

Modalities: BiologicSmall moleculeMonoclonal antibodyProteinPeptideVaccineLiposomal suspensionCytotoxic compound
Industry: Contract Manufacturing Organization

Partnerships

Not specified publicly; works with various pharmaceutical/biotech companies as contract manufacturer.

Beyond the preview

Go deeper on OSO BioPharmaceuticals Manufacturing.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OSO BioPharmaceuticals Manufacturing.

Explore the full profile